Tuesday, October 20, 2026, 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
April 13, 2017—The Digital Pathology community is in full support of the FDA’s landmark announcement that Philips Whole Slide Imaging (WSI) system, IntelliSite, can be marketed for primary diagnosis. This technology facilitates review of digital surgical pathology slides with remote sign out capabilities, and poses a significant benefit to both pathologists and patients alike.
Dec. 2, 2016—A new white paper from Orchard Software titled “Point-of-care Testing: The Great Boom Ahead” discusses the history of POC testing connectivity and shares specific case study savings and improvements associated with the adoption of a POC testing connectivity and management solution. Read the white paper.
Oct. 5, 2016—Clinical laboratories and pathology groups ought to master the emerging areas of pharmacodynamics and pharmacokinetics that open the door to a more personalized approach to drug prescribing, says a free (registration required) white paper published by Dark Daily. Read. By identifying drugs most likely to benefit a patient, assessing the likely dose response, potentially avoiding adverse reactions, and reducing unnecessary use of drugs, pharmacogenomics testing can help optimize treatment and reduce costs associated with complications or inappropriate utilization.
Sept. 14, 2016—Donna Mayne, the microbiology, serology, and molecular laboratory manager at Sacred Heart Health System in Pensacola, Fla., outlines the clinical benefits of using molecular technology to detect Mycoplasma pneumoniae in a free program provided by Meridian Bioscience. Watch. In a separate presentation, Vicki Chalker, PhD, head of the respiratory and vaccine-preventable bacteria reference unit of Public Health England’s National Infection Service, discusses the importance of testing for M. pneumoniae and the diagnostic methodologies available. Meridian’s M. pneumoniae test
Aug. 29, 2016—An Archives of Pathology & Laboratory Medicine study analyzes evidence from nine postmortem examinations and related studies of fetuses and infants with intrauterine Zika virus infection and microcephaly. Author David A. Schwartz, MD, concludes “the Zika virus has a strong predilection for cells of the fetal central nervous system following vertical transmission.” Read the early online release.
Aug. 19, 2016—Pathologists have an opportunity to thrive and be health care team leaders in the coming world of accountable and value-based care, Donald Karcher, MD, argues in a webinar that offers a sneak peek of a course that he will moderate at CAP16 in Las Vegas. View the free, 30-minute webinar (registration required).
May 18, 2016—A free webinar sponsored by Sigma-Aldrich will review the utility of immunohistochemical testing with markers such as S-100, SOX-10, Ber-Ep4, and HHV-8 in accurately diagnosing skin cancer and improving survival rates for patients with the disease. Register. Continuing education credits for pathologists and histotechnologists attending this webinar will be offered through the National Society of Histotechnology. The speaker, Jeff Gordon, has more than 15 years of IHC diagnostic experience and conducted more than two dozen NSH-approved workshops.
March 17, 2016—As molecular technology and personalized medicine increasingly becomes the default position for clinical diagnostics laboratories, these modalities place significant demands on laboratory information systems. That is where molecular information management systems come into the picture. A white paper from The Dark Report and Dark Daily examines how pathologists are using MIMS to handle the complex workflows of various molecular platforms and modalities.
Feb. 17, 2016—Two microbiology leaders will take part in a live, online panel discussion, “Tackling the U.S. Healthcare System’s Infectious Disease Management Problem,” Feb. 23, noon Central time. They will explore approaches to reducing antibiotic resistance, rapidly identifying pathogens in their patients, and controlling infectious disease in the hospital and the community. One approach that will be covered is the role of advanced molecular diagnostics in the clinical microbiology laboratory. Register. Speakers at the online panel will be: Margret Oethinger,
Dec. 9, 2015—A Jan. 13 webinar hosted by Orchard Software will explore how laboratories can embrace the transformation taking place in health care. The free webinar aims to help laboratory professionals maximize efficient, oversee test use, add interpretations to test results, reevaluate test menus, provide analytics, and save money across the health care organization. Register.
